Single-cell RNA-sequencing Can Resolve Malignant, Non-malignant Heterogeneity

June 14, 2016 Leave a comment 2,334 Views

from CancerTherapyAdvisor by Jason Hoffman, PharmD, RPh – CHICAGO —Single-cell RNA-sequencing can resolve the heterogeneity of both malignant and non-malignant tumor components, according to findings presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting. Current profiling technologies provide ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: American Society of Clinical Oncology

Single-cell RNA-sequencing Can Resolve Malignant, Non-malignant Heterogeneity

CLEARER – a machine learning approach for predicting essential genes across eukaryotes

scRNA-Seq reveals how genetic ancestry shapes immune response to influenza virus

Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistance

Microwell-seq – high-throughput screening with single-cell transcriptional profiling

Postdoc position available – computational biology: tumour heterogeneity and resistance mechanisms

CellHeap – a workflow for optimizing COVID-19 single-cell RNA-Seq data processing

Automation enables high-throughput and reproducible single-cell transcriptomics library preparation